NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 7th March 2011 A report from the NHS Information Centre has assessed the variation in the use, by the NHS in England in 2009, of 18 groups of medicines considered […]
Category Archives: Other therapeutics
NPC Archive Item: EMA gives go-ahead for ranibizumab▼ for diabetic macular oedema
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 21 January 2011 The European Medicines Agency (EMA) issued a positive opinion in October 2010 for a licence extension for ranibizumab▼ for the treatment of adults with visual impairment […]
NPC Archive Item: Long-term, low-dose aspirin may reduce risk of death from some cancers
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 December 2010 A meta-analysis of eight trials found that patients treated with aspirin were less likely to die from many common cancers during those trials. Follow-up analysis of participants […]
NPC Archive Item: December Drug Safety Update: a reminder not to use fibrates first line routinely
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 20 December 2010 The MHRA and CHM have published the December edition of Drug Safety Update. This edition includes advice […]
NPC Archive Item: How does the usage of medicines in the UK compare with that in other countries?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 October 2010 A report has considered the extent and causes of variations in drug usage among 14 developed countries. It found that although some emerge as generally high […]
NPC Archive Item: Are oral bisphosphonates associated with an increased risk of oesophageal cancer?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 7 October 2010 A UK case-control study suggests a small increased risk of oesophageal cancer (but not stomach or colorectal cancer) in people with previous prescriptions for oral bisphosphonates. […]
NPC Archive Item: Prolonged-release fampridine improves measures of walking in some patients with multiple sclerosis
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 23 August 2010 In a phase III, double-blind placebo-controlled trial, MS-F203, of 301 patients with multiple sclerosis (MS), prolonged-release fampridine improved walking speed in the 35% of patients who responded […]
NPC Archive Item: NICE recommends infliximab or adalimumab▼ as options for Crohn’s disease
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 June 2010 NICE technology appraisal guidance 187 recommends infliximab (adults and children over 6 years old) or adalimumab▼ (adults only), as treatment options for patients with severe active […]
NPC Archive Item: June Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 14 June 2010 The MHRA and CHM have published the June edition of Drug Safety Update. This edition includes: […]
NPC Archive Item: Increased risk of C difficile infections and of fractures: two more good reasons to review PPI prescribing
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 3 June 2010 A group of US studies published under the theme ‘less is more’ adds to earlier evidence around two potential harms associated with proton pump inhibitor (PPI) […]